| Neurologic toxicity of immune checkpoint inhibitors: a review of literature V Albarrán, J Chamorro, DI Rosero, C Saavedra, A Soria, A Carrato, ... Frontiers in Pharmacology 13, 774170, 2022 | 24 | 2022 |
| Receptor tyrosine kinase inhibitors for the treatment of recurrent and unresectable bone sarcomas V Albarrán, ML Villamayor, J Chamorro, DI Rosero, J Pozas, ... International Journal of Molecular Sciences 23 (22), 13784, 2022 | 14 | 2022 |
| Her-2 targeted therapy in advanced urothelial cancer: from monoclonal antibodies to antibody-drug conjugates V Albarrán, DI Rosero, J Chamorro, J Pozas, M San Román, AM Barrill, ... International Journal of Molecular Sciences 23 (20), 12659, 2022 | 13 | 2022 |
| Recurrent glioblastoma: a review of the treatment options MA Vaz-Salgado, M Villamayor, V Albarrán, V Alía, P Sotoca, J Chamorro, ... Cancers 15 (17), 4279, 2023 | 12 | 2023 |
| Novel tyrosine kinase targets in urothelial carcinoma J Torres-Jiménez, V Albarrán-Fernández, J Pozas, MS Román-Gil, ... International Journal of Molecular Sciences 22 (2), 747, 2021 | 9 | 2021 |
| Current landscape and potential challenges of immune checkpoint inhibitors in microsatellite stable metastatic colorectal carcinoma M San-Román-Gil, J Torres-Jiménez, J Pozas, J Esteban-Villarrubia, ... Cancers 15 (3), 863, 2023 | 8 | 2023 |
| Androgen receptor signaling inhibition in advanced castration resistance prostate cancer: what is expected for the near future? J Pozas, S Álvarez Rodríguez, VA Fernández, J Burgos, M Santoni, ... Cancers 14 (24), 6071, 2022 | 8 | 2022 |
| Current landscape of immunotherapy for advanced sarcoma V Albarrán, ML Villamayor, J Pozas, J Chamorro, DI Rosero, ... Cancers 15 (8), 2287, 2023 | 7 | 2023 |
| Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature V Albarrán, J Pozas, F Rodríguez, Á Carrasco, E Corral, Y Lage, ... Translational Lung Cancer Research 10 (7), 3303, 2021 | 6 | 2021 |
| Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report J Pozas, V Albarrán-Fernández, L González-Campo, ME Olmedo-García, ... Translational Lung Cancer Research 11 (7), 1497, 2022 | 3 | 2022 |
| BRAF inhibitors in metastatic colorectal cancer and mechanisms of resistance: a review of the literature P Guerrero, V Albarrán, M San Román, C González-Merino, ... Cancers 15 (21), 5243, 2023 | 2 | 2023 |
| Adoptive T cell therapy for solid tumors: current landscape and future challenges V Albarrán, M San Román, J Pozas, J Chamorro, DI Rosero, P Guerrero, ... Frontiers in Immunology 15, 1352805, 2024 | 1 | 2024 |
| Biomarkers for response to TIL therapy: a comprehensive review VA Fernández, PB Martínez, JS Granhøj, TH Borch, M Donia, IM Svane Journal for Immunotherapy of Cancer 12 (3), 2024 | 1 | 2024 |
| 479P Survival outcomes of resected gastroesophageal cancer and impact of active surveillance: Experience from a tertiary centre J Chamorro-Perez, GG Martín, EC de la Fuente, VA Fernández, ... Annals of Oncology 35, S191, 2024 | | 2024 |
| Impact of steroids indication on the efficacy of immunotherapy in a multi-tumor cohort of patients: Time and dose-dependent evaluation. P Gajate, V Albarrán, P Guerrero, C García de Quevedo Suero, ... Journal of Clinical Oncology 42 (16_suppl), 12083-12083, 2024 | | 2024 |
| Negative impact of steroids on the efficacy of immunotherapy in a multi-tumor cohort: time and dose-dependent V Albarrán, P Guerrero, CG de Quevedo, C González, J Chamorro, ... | | 2024 |
| Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature M San-Román-Gil, I Martínez-Delfrade, V Albarrán-Fernández, ... Frontiers in Immunology 15, 1352262, 2024 | | 2024 |
| 513P Cyclin pathway in oligodendrogliomas IDH mut and 1p/19q codeleted MAV Salgado, JMS Sanchez, J Earl, A Perez, H Pian, Y Ruano, ... Annals of Oncology 34, S397, 2023 | | 2023 |
| 533P Oligodendrogliomas: What is the impact after the introduction of the WHO molecular classification? MAV Salgado, J Earl, JMS Sanchez, Y Ruano, J Gutierrez, H Pian, LL Ley, ... Annals of Oncology 34, S403-S404, 2023 | | 2023 |
| 2180P Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients V Albarrán, JJ Serrano, P Sotoca-Rubio, AMB Corpa, VA Navarro, ... Annals of Oncology 34, S1129-S1130, 2023 | | 2023 |
